Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
Christopher D. Cox, Michael J. Breslin, David B. Whitman, et al.
Journal of Medicinal Chemistry (2010) Vol. 53, Iss. 14, pp. 5320-5332
Closed Access | Times Cited: 348

Showing 1-25 of 348 citing articles:

Click Chemistry: 1,2,3‐Triazoles as Pharmacophores
Sandip G. Agalave, Suleman R. Maujan, Vandana S. Pore
Chemistry - An Asian Journal (2011) Vol. 6, Iss. 10, pp. 2696-2718
Closed Access | Times Cited: 1190
The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules
Tanaji T. Talele
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 19, pp. 8712-8756
Closed Access | Times Cited: 792
Reductive Amination in the Synthesis of Pharmaceuticals
Oleg I. Afanasyev, Ekaterina A. Kuchuk, Dmitry L. Usanov, et al.
Chemical Reviews (2019) Vol. 119, Iss. 23, pp. 11857-11911
Closed Access | Times Cited: 601
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
David Michelson, Ellen Snyder, Erin M. Paradis, et al.
The Lancet Neurology (2014) Vol. 13, Iss. 5, pp. 461-471
Closed Access | Times Cited: 480
The role of orexin in motivated behaviours
Takeshi Sakurai
Nature reviews. Neuroscience (2014) Vol. 15, Iss. 11, pp. 719-731
Closed Access | Times Cited: 414
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Tobias Atkin, Stefano Comai, Gabriella Gobbi
Pharmacological Reviews (2018) Vol. 70, Iss. 2, pp. 197-245
Open Access | Times Cited: 306
Orexin receptor antagonism for treatment of insomnia
W. Joseph Herring, Ellen Snyder, Kerry Budd, et al.
Neurology (2012) Vol. 79, Iss. 23, pp. 2265-2274
Closed Access | Times Cited: 298
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
W. Joseph Herring, Kathryn M. Connor, Neely Ivgy-May, et al.
Biological Psychiatry (2014) Vol. 79, Iss. 2, pp. 136-148
Closed Access | Times Cited: 257
Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist
Christopher J. Winrow, Anthony L. Gotter, Christopher D. Cox, et al.
Journal of Neurogenetics (2011) Vol. 25, Iss. 1-2, pp. 52-61
Closed Access | Times Cited: 255
Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Leslie Citrome
International Journal of Clinical Practice (2014) Vol. 68, Iss. 12, pp. 1429-1441
Open Access | Times Cited: 246
Photo-induced oxidant-free oxidative C–H/N–H cross-coupling between arenes and azoles
Linbin Niu, Hong Yi, Shengchun Wang, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 206
Lhx6-positive GABA-releasing neurons of the zona incerta promote sleep
Kai Liu, Juhyun Kim, Dong Won Kim, et al.
Nature (2017) Vol. 548, Iss. 7669, pp. 582-587
Open Access | Times Cited: 204
Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant
Jie Yin, Juan Carlos Mobarec, Peter Kolb, et al.
Nature (2014) Vol. 519, Iss. 7542, pp. 247-250
Closed Access | Times Cited: 203
Metallaphotoredox-Catalyzed Cross-Electrophile Csp3–Csp3 Coupling of Aliphatic Bromides
Russell T. Smith, Xiaheng Zhang, Juan A. Rincón, et al.
Journal of the American Chemical Society (2018) Vol. 140, Iss. 50, pp. 17433-17438
Open Access | Times Cited: 182
Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
W. Joseph Herring, Paulette Ceesay, Ellen Snyder, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 3, pp. 541-551
Open Access | Times Cited: 138
Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation
Chuan Hong, Noel Byrne, Beata Zamlynny, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 104
Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71
Late-Stage C(sp3)–H Methylation of Drug Molecules
Edna Mao, David W. C. MacMillan
Journal of the American Chemical Society (2023) Vol. 145, Iss. 5, pp. 2787-2793
Open Access | Times Cited: 67
The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress
Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 448-448
Open Access | Times Cited: 22
Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal
Takeshi Sakurai, Michihiro Mieda
Trends in Pharmacological Sciences (2011) Vol. 32, Iss. 8, pp. 451-462
Open Access | Times Cited: 211
New paradigms in GPCR drug discovery
Kenneth A. Jacobson
Biochemical Pharmacology (2015) Vol. 98, Iss. 4, pp. 541-555
Open Access | Times Cited: 163
International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology
Anthony L. Gotter, Andrea L. Webber, Paul J. Coleman, et al.
Pharmacological Reviews (2012) Vol. 64, Iss. 3, pp. 389-420
Closed Access | Times Cited: 154
Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men
Hong Sun, William P. Kennedy, Darren Wilbraham, et al.
SLEEP (2013)
Open Access | Times Cited: 149
Discovery and development of orexin receptor antagonists as therapeutics for insomnia
Christopher J. Winrow, John J. Renger
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 283-293
Open Access | Times Cited: 144
Highly N2‐Selective Palladium‐Catalyzed Arylation of 1,2,3‐Triazoles
Satoshi Ueda, Mingjuan Su, Stephen L. Buchwald
Angewandte Chemie International Edition (2011) Vol. 50, Iss. 38, pp. 8944-8947
Open Access | Times Cited: 141
Page 1 - Next Page

Scroll to top